The company provides contract research services to the biopharma industry through its immunization toolkit, which combines advanced immunization methods with B cell screening and hybridoma-based antibody discovery technologies. Abveris partners with leading biopharmaceutical scientists to offer comprehensive gene-to-antibody discovery services, from early project design to final product delivery, for diverse pharmaceutical and industrial applications. As a world leader in in vivo antibody discovery and a division of Twist Bioscience, Abveris is committed to advancing the field of antibody discovery.